265 related articles for article (PubMed ID: 24990484)
1. A model in which heat shock protein 90 targets protein-folding clefts: rationale for a new approach to neuroprotective treatment of protein folding diseases.
Pratt WB; Morishima Y; Gestwicki JE; Lieberman AP; Osawa Y
Exp Biol Med (Maywood); 2014 Nov; 239(11):1405-13. PubMed ID: 24990484
[TBL] [Abstract][Full Text] [Related]
2. Targeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases.
Pratt WB; Gestwicki JE; Osawa Y; Lieberman AP
Annu Rev Pharmacol Toxicol; 2015; 55():353-71. PubMed ID: 25292434
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradation.
Wang AM; Morishima Y; Clapp KM; Peng HM; Pratt WB; Gestwicki JE; Osawa Y; Lieberman AP
J Biol Chem; 2010 May; 285(21):15714-23. PubMed ID: 20348093
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein.
Waza M; Adachi H; Katsuno M; Minamiyama M; Tanaka F; Doyu M; Sobue G
J Mol Med (Berl); 2006 Aug; 84(8):635-46. PubMed ID: 16741751
[TBL] [Abstract][Full Text] [Related]
5. Proposal for a role of the Hsp90/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage.
Pratt WB; Morishima Y; Peng HM; Osawa Y
Exp Biol Med (Maywood); 2010 Mar; 235(3):278-89. PubMed ID: 20404045
[TBL] [Abstract][Full Text] [Related]
6. A screen for enhancers of clearance identifies huntingtin as a heat shock protein 90 (Hsp90) client protein.
Baldo B; Weiss A; Parker CN; Bibel M; Paganetti P; Kaupmann K
J Biol Chem; 2012 Jan; 287(2):1406-14. PubMed ID: 22123826
[TBL] [Abstract][Full Text] [Related]
7. Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network.
Yu A; Fox SG; Cavallini A; Kerridge C; O'Neill MJ; Wolak J; Bose S; Morimoto RI
J Biol Chem; 2019 May; 294(19):7917-7930. PubMed ID: 30936201
[TBL] [Abstract][Full Text] [Related]
8. Interplay between the Hsp90 Chaperone and the HslVU Protease To Regulate the Level of an Essential Protein in Shewanella oneidensis.
Honoré FA; Maillot NJ; Méjean V; Genest O
mBio; 2019 May; 10(3):. PubMed ID: 31088919
[TBL] [Abstract][Full Text] [Related]
9. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
Chaari A; Hoarau-Véchot J; Ladjimi M
Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.
Reis SD; Pinho BR; Oliveira JMA
Mol Neurobiol; 2017 Oct; 54(8):5829-5854. PubMed ID: 27660272
[TBL] [Abstract][Full Text] [Related]
11. Modulation of heme/substrate binding cleft of neuronal nitric-oxide synthase (nNOS) regulates binding of Hsp90 and Hsp70 proteins and nNOS ubiquitination.
Peng HM; Morishima Y; Pratt WB; Osawa Y
J Biol Chem; 2012 Jan; 287(2):1556-65. PubMed ID: 22128174
[TBL] [Abstract][Full Text] [Related]
12. Impaired heat shock response in cells expressing full-length polyglutamine-expanded huntingtin.
Chafekar SM; Duennwald ML
PLoS One; 2012; 7(5):e37929. PubMed ID: 22649566
[TBL] [Abstract][Full Text] [Related]
13. Balance between folding and degradation for Hsp90-dependent client proteins: a key role for CHIP.
Kundrat L; Regan L
Biochemistry; 2010 Sep; 49(35):7428-38. PubMed ID: 20704274
[TBL] [Abstract][Full Text] [Related]
14. Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG).
Waza M; Adachi H; Katsuno M; Minamiyama M; Tanaka F; Sobue G
Ann N Y Acad Sci; 2006 Nov; 1086():21-34. PubMed ID: 17185503
[TBL] [Abstract][Full Text] [Related]
15. Isoform-selective Genetic Inhibition of Constitutive Cytosolic Hsp70 Activity Promotes Client Tau Degradation Using an Altered Co-chaperone Complement.
Fontaine SN; Rauch JN; Nordhues BA; Assimon VA; Stothert AR; Jinwal UK; Sabbagh JJ; Chang L; Stevens SM; Zuiderweg ER; Gestwicki JE; Dickey CA
J Biol Chem; 2015 May; 290(21):13115-27. PubMed ID: 25864199
[TBL] [Abstract][Full Text] [Related]
16. Hsp90 Chaperones Bluetongue Virus Proteins and Prevents Proteasomal Degradation.
Mohl BP; Roy P
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375577
[TBL] [Abstract][Full Text] [Related]
17. Heat shock factor 2 is required for maintaining proteostasis against febrile-range thermal stress and polyglutamine aggregation.
Shinkawa T; Tan K; Fujimoto M; Hayashida N; Yamamoto K; Takaki E; Takii R; Prakasam R; Inouye S; Mezger V; Nakai A
Mol Biol Cell; 2011 Oct; 22(19):3571-83. PubMed ID: 21813737
[TBL] [Abstract][Full Text] [Related]
18. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances.
Muller P; Ruckova E; Halada P; Coates PJ; Hrstka R; Lane DP; Vojtesek B
Oncogene; 2013 Jun; 32(25):3101-10. PubMed ID: 22824801
[TBL] [Abstract][Full Text] [Related]
19. Targeting Hsp70 facilitated protein quality control for treatment of polyglutamine diseases.
Davis AK; Pratt WB; Lieberman AP; Osawa Y
Cell Mol Life Sci; 2020 Mar; 77(6):977-996. PubMed ID: 31552448
[TBL] [Abstract][Full Text] [Related]
20. The Hsp70-Hsp90 Chaperone Cascade in Protein Folding.
Morán Luengo T; Mayer MP; Rüdiger SGD
Trends Cell Biol; 2019 Feb; 29(2):164-177. PubMed ID: 30502916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
